CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...